138 related articles for article (PubMed ID: 36197797)
21. H3K36ac Is an Evolutionary Conserved Plant Histone Modification That Marks Active Genes.
Mahrez W; Arellano MS; Moreno-Romero J; Nakamura M; Shu H; Nanni P; Köhler C; Gruissem W; Hennig L
Plant Physiol; 2016 Mar; 170(3):1566-77. PubMed ID: 26764380
[TBL] [Abstract][Full Text] [Related]
22. LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling.
Chang J; Nicolau MM; Cox TR; Wetterskog D; Martens JW; Barker HE; Erler JT
Breast Cancer Res; 2013; 15(4):R67. PubMed ID: 23971878
[TBL] [Abstract][Full Text] [Related]
23. LOXL2-mediated chromatin compaction is required to maintain the oncogenic properties of triple-negative breast cancer cells.
Serra-Bardenys G; Blanco E; Escudero-Iriarte C; Serra-Camprubí Q; Querol J; Pascual-Reguant L; Morancho B; Escorihuela M; Tissera NS; Sabé A; Martín L; Segura-Bayona S; Verde G; Aiese Cigliano R; Millanes-Romero A; Jerónimo C; Cebrià-Costa JP; Nuciforo P; Simonetti S; Viaplana C; Dienstmann R; Oliveira M; Peg V; Stracker TH; Arribas J; Canals F; Villanueva J; Di Croce L; García de Herreros A; Tian TV; Peiró S
FEBS J; 2024 Jun; 291(11):2423-2448. PubMed ID: 38451841
[TBL] [Abstract][Full Text] [Related]
24. Clinical Implications of Lysyl Oxidase-Like Protein 2 Expression in Pancreatic Cancer.
Tanaka N; Yamada S; Sonohara F; Suenaga M; Hayashi M; Takami H; Niwa Y; Hattori N; Iwata N; Kanda M; Tanaka C; Kobayashi D; Nakayama G; Koike M; Fujiwara M; Fujii T; Kodera Y
Sci Rep; 2018 Jun; 8(1):9846. PubMed ID: 29959362
[TBL] [Abstract][Full Text] [Related]
25. Lysyl oxidase-like 2 represses Notch1 expression in the skin to promote squamous cell carcinoma progression.
Martin A; Salvador F; Moreno-Bueno G; Floristán A; Ruiz-Herguido C; Cuevas EP; Morales S; Santos V; Csiszar K; Dubus P; Haigh JJ; Bigas A; Portillo F; Cano A
EMBO J; 2015 Apr; 34(8):1090-109. PubMed ID: 25759215
[TBL] [Abstract][Full Text] [Related]
26. Lysyl oxidase-like 2 promotes esophageal squamous cell carcinoma cell migration independent of catalytic activity.
Zou H; Wen B; Li RL; Zhan XH; Jiao JW; Liao LD; Wu BL; Xie WM; Xu LY; Li EM
Int J Biochem Cell Biol; 2020 Aug; 125():105795. PubMed ID: 32580015
[TBL] [Abstract][Full Text] [Related]
27. Receptor activity modifying protein-3 mediates the protumorigenic activity of lysyl oxidase-like protein-2.
Brekhman V; Lugassie J; Zaffryar-Eilot S; Sabo E; Kessler O; Smith V; Golding H; Neufeld G
FASEB J; 2011 Jan; 25(1):55-65. PubMed ID: 20802105
[TBL] [Abstract][Full Text] [Related]
28. Lysyl Oxidase-Like Protein 2 Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer.
Wang C; Xu S; Tian Y; Ju A; Hou Q; Liu J; Fu Y; Luo Y
Neoplasia; 2019 Apr; 21(4):413-427. PubMed ID: 30925417
[TBL] [Abstract][Full Text] [Related]
29. Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis.
Pollheimer MJ; Racedo S; Mikels-Vigdal A; Marshall D; Bowlus C; Lackner C; Madl T; Karlsen TH; Hov JR; Lyman SK; Adamkewicz J; Smith V; Moreau E; Zollner G; Eide TJ; Stojakovic T; Scharnagl H; Gruber HJ; Stauber RE; Trauner M; Fickert P
J Hepatol; 2018 Aug; 69(2):368-377. PubMed ID: 29709678
[TBL] [Abstract][Full Text] [Related]
30. Lysyl oxidase-like 2 (LOXL2) oxidizes trimethylated lysine 4 in histone H3.
Herranz N; Dave N; Millanes-Romero A; Pascual-Reguant L; Morey L; Díaz VM; Lórenz-Fonfría V; Gutierrez-Gallego R; Jerónimo C; Iturbide A; Di Croce L; García de Herreros A; Peiró S
FEBS J; 2016 Dec; 283(23):4263-4273. PubMed ID: 27735137
[TBL] [Abstract][Full Text] [Related]
31. Lysyl oxidase-like 2 is a regulator of angiogenesis through modulation of endothelial-to-mesenchymal transition.
de Jong OG; van der Waals LM; Kools FRW; Verhaar MC; van Balkom BWM
J Cell Physiol; 2019 Jul; 234(7):10260-10269. PubMed ID: 30387148
[TBL] [Abstract][Full Text] [Related]
32. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma.
Lin S; Zheng L; Lu Y; Xia Q; Zhou P; Liu Z
Cancer Med; 2020 Nov; 9(22):8624-8638. PubMed ID: 32970930
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of lysyl oxidase-like 2 (LOXL2) is associated with disease progression in lung adenocarcinomas.
Zhan P; Shen XK; Qian Q; Zhu JP; Zhang Y; Xie HY; Xu CH; Hao KK; Hu W; Xia N; Lu GJ; Yu LK
Med Oncol; 2012 Jun; 29(2):648-55. PubMed ID: 21519871
[TBL] [Abstract][Full Text] [Related]
35. LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion.
Zhan XH; Jiao JW; Zhang HF; Xu XE; He JZ; Li RL; Zou HY; Wu ZY; Wang SH; Wu JY; Liao LD; Wang JJ; Cheng YW; Zhang K; Neufeld G; Xu LY; Li EM
Cancer Res; 2019 Oct; 79(19):4951-4964. PubMed ID: 31409639
[TBL] [Abstract][Full Text] [Related]
36. LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma.
Shao B; Zhao X; Liu T; Zhang Y; Sun R; Dong X; Liu F; Zhao N; Zhang D; Wu L; Wang Y; Wang M; Meng J; Lin X; Sun B
J Cell Mol Med; 2019 Feb; 23(2):1363-1374. PubMed ID: 30506621
[TBL] [Abstract][Full Text] [Related]
37. LOXL2-dependent deacetylation of aldolase A induces metabolic reprogramming and tumor progression.
Jiao JW; Zhan XH; Wang JJ; He LX; Guo ZC; Xu XE; Liao LD; Huang X; Wen B; Xu YW; Hu H; Neufeld G; Chang ZJ; Zhang K; Xu LY; Li EM
Redox Biol; 2022 Nov; 57():102496. PubMed ID: 36209516
[TBL] [Abstract][Full Text] [Related]
38. The LOXL2 gene encodes a new lysyl oxidase-like protein and is expressed at high levels in reproductive tissues.
Jourdan-Le Saux C; Tronecker H; Bogic L; Bryant-Greenwood GD; Boyd CD; Csiszar K
J Biol Chem; 1999 Apr; 274(18):12939-44. PubMed ID: 10212285
[TBL] [Abstract][Full Text] [Related]
39. Loxl2 and Loxl3 Paralogues Play Redundant Roles during Mouse Development.
Santamaría PG; Dubus P; Bustos-Tauler J; Floristán A; Vázquez-Naharro A; Morales S; Cano A; Portillo F
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628534
[TBL] [Abstract][Full Text] [Related]
40. Oligomeric States and Hydrodynamic Properties of Lysyl Oxidase-Like 2.
Meier AA; Moon HJ; Toth R; Folta-Stogniew E; Kuczera K; Middaugh CR; Mure M
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
